Lv1
22 积分 2025-05-28 加入
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion
4天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
4天前
已完结
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
4天前
已完结
CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
4天前
已完结
BCMAxCD3 Bispecific Yields Robust Responses in Myeloma
4天前
已完结
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody
4天前
已完结
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma
4天前
待确认
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy
4天前
已完结
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma
4天前
已完结
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
4天前
已完结
皖公网安备34019202002308
